Mega Lifesciences Public Company Limited Mega Lifesciences Public Company Limited

Mega Lifesciences Public Company Limited

MEGA

Rank in Stocks #9080
Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company... Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, operates as a comprehensive pharmaceutical and wellness enterprise. Its primary activities encompass the development, promotion, and distribution of a broad spectrum of health-related products, including nutritional supplements, prescription medicines, over-the-counter (OTC) remedies, botanical solutions, vitamins, and everyday consumer goods. The company structures its operations across three main divisions: Brands, Distribution, and Original Equipment Manufacture. Mega Lifesciences offers an extensive array of complementary medicines targeting various health concerns such as bone and joint health, pediatric care, diabetes management, cardiovascular support, digestive and liver wellness, skin health, weight management, overall well-being, men's and women's specific needs, and sports nutrition. Its OTC portfolio addresses common issues like gastrointestinal discomfort and pain. Furthermore, the prescription drug division covers crucial therapeutic areas including iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain relief, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its proprietary product lines, the company also provides third-party logistical and marketing services. Additionally, Mega Lifesciences is involved in managing wellness centers and offers specialized services in software design, development, and related technological solutions. The company maintains a significant global footprint, with operations spanning the Asia Pacific region, the Middle East, Africa, and the Commonwealth of Independent States.
Share Price
$1.05
Last synced: 2026-11-10
Market Cap
$913.76M
Change (1 day)
-1.41%
Change (1 year)
14.15%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Mega Lifesciences Public Company Limited (MEGA)

Category

Healthcare
Dividend history for Mega Lifesciences Public Company Limited (MEGA)
Mega Lifesciences Public Company Limited (stock symbol: MEGA) made a total of 26 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.39
Dividend yield (TTM) : 5.00%
Dividend payments for Mega Lifesciences Public Company Limited (MEGA) from 2014 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $0.0511 5.50%
2025 $0.0484 5.11%
2024 $0.046 -2.24%
2023 $0.0471 0.89%
2022 $0.0467 39.18%
2021 $0.0335 36.71%
2020 $0.0245 7.83%
2019 $0.0228 2.10%
2018 $0.0223 40.72%
2017 $0.0158 17.86%
2016 $0.0134 10.50%
2015 $0.0122 39.73%
2014 $0.0087 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.0511 5.50%
2025 $0.0484 5.11%
2024 $0.046 -2.24%
2023 $0.0471 0.89%
2022 $0.0467 39.18%
2021 $0.0335 36.71%
2020 $0.0245 7.83%
2019 $0.0228 2.10%
2018 $0.0223 40.72%
2017 $0.0158 17.86%
2016 $0.0134 10.50%
2015 $0.0122 39.73%
2014 $0.0087 0.00%
Dividend payments for similar companies or competitors

Questions about Mega Lifesciences Public Company Limited's dividend per share

What is Mega Lifesciences Public Company Limited's dividend per share?

Mega Lifesciences Public Company Limited's dividend per share over the last twelve months is $0.05, as of Aug 2026.

What was Mega Lifesciences Public Company Limited's dividend per share in 2025?

In 2025, Mega Lifesciences Public Company Limited's dividend per share was $0.05, 5.11% more than in 2024 ($0.05).

How has Mega Lifesciences Public Company Limited's dividend per share changed since 2020?

From 2020 to 2025, Mega Lifesciences Public Company Limited's dividend per share went from $0.02 to $0.05, an average growth of 14.55% a year.